A detailed history of Summit Financial Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Summit Financial Group, Inc. holds 31,902 shares of PFE stock, worth $840,936. This represents 0.32% of its overall portfolio holdings.

Number of Shares
31,902
Previous 32,252 1.09%
Holding current value
$840,936
Previous $928,000 4.63%
% of portfolio
0.32%
Previous 0.36%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 05, 2024

SELL
$25.89 - $29.73 $9,061 - $10,405
-350 Reduced 1.09%
31,902 $885,000
Q4 2023

Jan 12, 2024

BUY
$26.13 - $33.94 $3,658 - $4,751
140 Added 0.44%
32,252 $928,000
Q3 2023

Oct 17, 2023

SELL
$32.09 - $37.51 $75,732 - $88,523
-2,360 Reduced 6.85%
32,112 $1.07 Million
Q2 2023

Jul 13, 2023

SELL
$36.12 - $41.79 $67,002 - $77,520
-1,855 Reduced 5.11%
34,472 $1.26 Million
Q1 2023

Apr 11, 2023

SELL
$39.39 - $51.28 $11,580 - $15,076
-294 Reduced 0.8%
36,327 $1.48 Million
Q4 2022

Jan 09, 2023

SELL
$41.75 - $54.5 $44,547 - $58,151
-1,067 Reduced 2.83%
36,621 $1.88 Million
Q3 2022

Oct 12, 2022

SELL
$43.76 - $53.42 $20,129 - $24,573
-460 Reduced 1.21%
37,688 $1.65 Million
Q2 2022

Jul 07, 2022

SELL
$46.53 - $55.17 $6,979 - $8,275
-150 Reduced 0.39%
38,148 $2 Million
Q1 2022

Apr 08, 2022

BUY
$45.75 - $56.69 $134,962 - $167,235
2,950 Added 8.35%
38,298 $1.98 Million
Q4 2021

Jan 10, 2022

BUY
$41.32 - $61.25 $30,163 - $44,712
730 Added 2.11%
35,348 $2.09 Million
Q2 2021

Jul 06, 2021

BUY
$35.91 - $40.68 $8,977 - $10,170
250 Added 0.73%
34,618 $1.36 Million
Q1 2021

Apr 07, 2021

SELL
$33.49 - $37.77 $7,535 - $8,498
-225 Reduced 0.65%
34,368 $1.25 Million
Q4 2020

Jan 07, 2021

SELL
$33.47 - $42.56 $8,367 - $10,640
-250 Reduced 0.72%
34,593 $1.27 Million
Q2 2020

Jul 06, 2020

BUY
$30.12 - $36.54 $50,541 - $61,314
1,678 Added 5.06%
34,843 $1.14 Million
Q1 2020

Apr 03, 2020

SELL
$27.03 - $38.62 $1,135 - $1,622
-42 Reduced 0.13%
33,165 $1.08 Million
Q4 2019

Jan 06, 2020

SELL
$32.92 - $37.36 $20,904 - $23,723
-635 Reduced 1.88%
33,207 $1.3 Million
Q3 2019

Oct 09, 2019

SELL
$32.49 - $42.13 $143,670 - $186,298
-4,422 Reduced 11.56%
33,842 $1.22 Million
Q2 2019

Jul 03, 2019

SELL
$36.98 - $41.52 $222,175 - $249,452
-6,008 Reduced 13.57%
38,264 $1.66 Million
Q3 2018

Oct 03, 2018

SELL
$34.47 - $41.81 $1,654 - $2,006
-48 Reduced 0.11%
44,272 $1.95 Million
Q1 2018

Apr 04, 2018

BUY
$31.91 - $37.02 $57,438 - $66,636
1,800 Added 4.23%
44,320 $1.57 Million
Q4 2017

Jan 04, 2018

SELL
$33.26 - $35.29 $49,890 - $52,935
-1,500 Reduced 3.41%
42,520 $1.54 Million
Q3 2017

Oct 10, 2017

BUY
$31.0 - $34.15 $1.36 Million - $1.5 Million
44,020
44,020 $1.57 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Summit Financial Group, Inc. Portfolio

Follow Summit Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial Group, Inc. with notifications on news.